Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular

H Zhang1, I Ozaki, T Mizuta

  • 1Department of Internal Medicine, Division of Hepatology and Metabolism, Saga Medical School, Saga University, Saga, Japan.

Oncogene
|May 10, 2006
PubMed

Insights

Programmed cell death 4 (PDCD4) is downregulated in human hepatocellular carcinoma (HCC). PDCD4 acts as a tumor suppressor by inducing apoptosis in HCC cells, suggesting its role in preventing liver cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Programmed cell death 4 (PDCD4) is a known tumor suppressor, but its role in human hepatocellular carcinoma (HCC) requires further investigation.
  • Understanding PDCD4's function in HCC is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression levels of PDCD4 in human HCC tissues and cell lines.
  • To elucidate the role of PDCD4 in regulating apoptosis and its association with transforming growth factor-beta1 (TGF-beta1) signaling in HCC.

Main Methods:

  • Western blotting and immunohistochemical staining were used to assess PDCD4 protein levels in HCC tissues.
  • PDCD4 gene expression was manipulated in the Huh7 HCC cell line via cDNA transfection and antisense technology.
  • Apoptosis was induced and measured using characteristic markers like DNA laddering and nuclear fragmentation, alongside caspase activation and mitochondrial assays.
  • TGF-beta1 signaling pathway was modulated using TGF-beta1 treatment and Smad7 transfection.

Main Results:

  • PDCD4 protein was significantly downregulated in all tested HCC tissues compared to noncancerous liver tissue.
  • Overexpression of PDCD4 in Huh7 cells induced apoptosis, characterized by DNA fragmentation, caspase activation, and mitochondrial changes.
  • TGF-beta1 treatment increased PDCD4 expression and induced apoptosis in Huh7 cells, effects which were blocked by Smad7, an inhibitor of TGF-beta1 signaling.
  • Inhibition of PDCD4 expression rendered HCC cells resistant to TGF-beta1-induced apoptosis.

Conclusions:

  • PDCD4 functions as a proapoptotic factor in human HCC cells.
  • PDCD4 is involved in TGF-beta1-mediated apoptosis and may act as a tumor suppressor in hepatocarcinogenesis.
  • Targeting PDCD4 could be a potential therapeutic strategy for liver cancer.

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...